Skip to content
Abierto
Menu

Presolicitation

Illumina DRAGEN GCP Lvl 4 1-year License

75N98026Q01035

National Institutes of Health, National Institutes of Health Olao. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Response deadline

September 10, 2026 at 12:00 PM EDT

Closed 6 days ago. Posted September 2, 2026. Scheduled to archive September 25, 2026.

Description

As published on SAM.gov.

The National Institute of Neurological Disorders and Stroke (NINDS), Neurodegenerative Diseases Research Section (NDRS), requires a 12-month subscription/access to the Illumina DRAGEN GCP Level 4 platform to process approximately 1,300,000 GB of whole-genome sequencing data derived from 10,000 human genomes.

The platform must support graph-based alignment to the human reference genome (hg38), accurate variant calling, and detection of single-nucleotide variants, insertions/deletions, structural variants, copy number variants, and repeat expansions. The platform must be fully compatible with Illumina-generated sequencing data and existing DRAGEN-processed datasets.

The contractor shall provide access and operational availability of the DRAGEN GCP platform and processing capability sufficient to analyze the 10,000 genomes during the 12-month period of performance.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 2, 2026

    Presolicitation

    Due September 10, 2026 at 12:00 PM EDT. SAM.gov, notice ed9362c3eea947688176d52f6f931bac

Points of contact

Also open from this buyer